Asia-Pacific Interventional Oncology Market Overview:
The Asia-Pacific
Interventional Oncology Market estimated at
428.64 million USD in 2018 and is expected to reach 774.00 million USD by 2025, growing at a
compound annual rate of 8% over the
2018-2025 forecast period.
Interventional oncology is a branch of medical science that
deals with minimally invasive medical procedures performed by interventional
radiologists for the diagnosis, treatment and palliation of different types of
cancer. In interventional oncology procedures, various image-guided techniques
are used, such as computed tomography, fluoroscopy and ultrasound to diagnose
and treat the specific site affected by pain or cancer.
Browse details of 140
number of pages research report developed on Asia-Pacific
Interventional Oncology Market Research Report @ https://www.researchcosmos.com/reports/asia-pacific-interventional-oncology-market/44785236
Interventional oncology is used to treat primary or
metastatic cancers such as liver cancer, kidney cancer, lung cancer, prostate
cancer, breast cancer and pancreatic cancer. Most of these procedures are
performed on an outpatient basis or require to spend the night in the hospital.
Some of the popular procedures are pain relief, intra-arterial therapy, and
abstinence therapy and neoadjuvant procedures.
Drivers, Challenges
and Opportunities - Asia-Pacific Interventional
Oncology Market:
Minimally invasive techniques have been widely used to treat
cancer cells better than anticancer treatments such as radiotherapy, surgery
and daily chemotherapy. The growing demand for minimally invasive therapies has
become a key driver of market growth. This procedure can also be used to treat
other related complications and inoperable patients. In addition, health
professionals and patients are progressively adopting minimally invasive
procedures in interventional oncology because of the benefits of such
techniques like the reducing length of hospital stay, minimizing risk of
infection, shortened risk of complication, quick pain relief and rapid
recovery. These advantages, when using minimally invasive procedures, will
promote the growth of the Asia Pacific market for interventional oncology.
Ask Free Sample of
the Report @ https://www.researchcosmos.com/request/asia-pacific-interventional-oncology-market/44785236
Geographic
Segmentation:
It is anticipated that the Asia-Pacific interventional
oncology market will achieve a high CAGR during the forecast period due to the
high prevalence of cancer in highly populated countries of India and China,
rapidly changing health, several government initiatives to improve health care
in general, and increase in health spending per capita. In addition, it is
likely that increased investment by leading global oncology interventional
device companies in the region will contribute to the growth of this market
during the forecast period.
Key market players:
Some of the key players in the Asia Pacific interventional
oncology market include Boston Scientific Corporation, Medtronic plc, Terumo
Corporation, BTG plc, AngioDynamics, Inc., Ethicon, Inc. (Johnson &
Johnson), Merit Medical Systems, Inc. and Sirtex Medical Limited, Siemens
Healthineers, Eckert & Ziegler BEBIG, Varian Medical Systems, Inc.,
HealthTronics, Inc, etc.
For any queries,
inquire more @ https://www.researchcosmos.com/inquire/asia-pacific-interventional-oncology-market/44785236
About Us:
Research Cosmos is a provider of standard and customized
Industry research, business intelligence and consulting services across more
than 100 domains in different industries of the world. We host the trending
Industry reports of the world’s top-notch publishing companies, offering
services to a wide range of customers from students to fortune 500 companies
and discloses the hidden opportunities in every leading industry of the world.
Contact:
Kevin Stewart
kevin@researchcosmos.com
Global Sales Manager
Research Cosmos
+1 888 709 8757
No comments:
Post a Comment